JPMorgan's top biopharma picks for 2025
- Posted on February 20, 2025
- By CNBC
- 5 Views

JPMorgan's top biopharma picks for 2025

The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.